Phrase | Consultant | Town | Special Interests |
neuroendocrine cancer | *Consultant(s)* | *Towns* | Medical oncology, bile duct cancer, pancreatic cancer, neuroendocrine cancer, adrenal gland cancer, liver cancer |
neuroendocrine tumour | *Consultant(s)* | *Towns* | Clinical oncology, central nervous system malignancies, upper gastrointestinal malignancies, neuroendocrine tumour, colorectal malignancies, hepatobiliary malignancies, Urological malignancies |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, breast disease, upper gastrointestinal cancer, neuroendocrine tumours, chemotherapy |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, oesophagogastric cancer, pancreatobiliary cancer, colorectal cancer, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, hepatopancreatobiliary cancer, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, lung cancer and mesothelioma, neuroendocrine tumours, cancer of unknown primary, malignant melanoma, kidney cancer |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Clinical oncology, colorectal cancer, upper gastrointestinal cancer, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal oncology, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, liver cancer, oesophageal cancer, neuroendocrine tumours, pancreatic cancer |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancers, hepatobiliary malignancies, cancers of unknown origin, neuroendocrine tumours, bowel cancer, pancreatic cancer |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, neuroendocrine tumours, rare cancers, oesophagogastric cancer |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, breast cancer, colorectal cancer, carcinoma unknown primary, hepatobiliary cancer, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, germ cell tumours, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, upper and lower gastrointestinal cancer, mesothelioma, lung cancer, cancer of unknown primary, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancer, oesophagogastric cancer, hepatobiliary oncology, neuroendocrine tumours, pancreatic cancer |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, gastrointestinal cancer, biliary tract tumours, pancreatic cancer, cholangiocarcinomas, neuroendocrine tumours |
neuroendocrine tumours | *Consultant(s)* | *Towns* | Clinical oncology, pancreatic cancer, neuroendocrine tumours, bowel cancer, oesophageal cancer, liver cancer, colon cancer, gastrointestinal cancer |
pancreatic neuroendocrine tumours | *Consultant(s)* | *Towns* | Medical oncology, colorectal cancers, clinical trials, pancreatic neuroendocrine tumours, hepatobiliary cancers |
systemic therapy Iodine 131 MIBG for neuroendocrine tumours | *Consultant(s)* | *Towns* | Clinical oncology, radiotherapy, breast cancer, upper and lower gastrointestinal cancer, systemic therapy Iodine 131 MIBG for neuroendocrine tumours, gastrointestinal chemoradiotherapy, colorectal cancer |
|